Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis.
about
Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targetsDiagnosis and Management of Autoimmune Hepatitis: Current Status and Future DirectionsMagnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis24-Week Exposure to Oxidized Tyrosine Induces Hepatic Fibrosis Involving Activation of the MAPK/TGF-β1 Signaling Pathway in Sprague-Dawley Rats Model.Losartan may inhibit the progression of liver fibrosis in chronic HCV patients.Current and prospective pharmacotherapy for autoimmune hepatitis.Targeting apoptosis in autoimmune hepatitis.Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.Evolving paradigm of treatment for autoimmune hepatitis.Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.Targeting Hepatic Fibrosis in Autoimmune Hepatitis.The Management of Autoimmune Hepatitis Patients with Decompensated Cirrhosis: Real-World Experience and a Comprehensive Review.Reversal of liver cirrhosis: current evidence and expectations.Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis: A cohort study.Chinese consensus on the diagnosis and management of autoimmune hepatitis (2015).Astragalus and Paeoniae radix rubra extract inhibits liver fibrosis by modulating the transforming growth factor‑β/Smad pathway in rats.Swertiamarin Attenuates Experimental Rat Hepatic Fibrosis by Suppressing Angiotensin II-Angiotensin Type 1 Receptor-Extracellular Signal-Regulated Kinase Signaling.Nitric oxide is a potential mediator of hepatic inflammation and fibrogenesis in autoimmune hepatitis.Use of adjunctive prednisolone in the management of a cat with bilateral quadriceps contracture following trauma.Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications.Ultrasound findings in autoimmune hepatitis.Comparative efficacy and tolerability of treatments for adult autoimmune hepatitis: A systematic review and network meta-analysis.
P2860
Q27025680-A702BE48-B3EF-494E-8A6B-D990453696EFQ28076505-1781A2A7-4136-463C-BD66-F9195262506EQ30362976-47511BC6-F623-4040-9EF1-64D809163EAEQ36405669-C1CB7029-4E1D-402C-8AC0-D96B29497D71Q36924883-AD3A23B1-0AC1-4481-8F7D-3A3D096C159EQ38222882-B62766C3-1767-46F6-AB0E-66EF1C8DCB81Q38231217-71CA9B68-BB9F-4EE3-A434-24A1CD7E5BCCQ38496935-BC3D3207-5F79-40BE-A0AF-84F629C3B39FQ38730872-6F96F8A8-756C-4952-893E-A4BC4305BAE6Q38895458-6FE54826-C3C0-416C-9CE4-0CE7CC033547Q38902371-B30DD7A6-E53E-47F7-A5C6-A1F78919FED3Q38925324-822A74FE-4CA3-420B-9120-7FF0F43E12F5Q38974002-8CAD1A67-4B44-45B8-8AF8-79814E4EC17DQ40082361-BC56E90A-8F19-4C19-B2D2-815FBA1654C2Q40235009-811ACE3D-3FA0-42EA-9DCC-FC0CE08F213AQ42074829-494A829E-05D4-4A41-8FAA-AC43DBED9E0BQ50230517-0EC9CC08-2632-43BC-9A45-9851EC618AFCQ53672240-0D929365-76E5-45D7-B67E-E55B321A2413Q54960718-3F9353F3-3880-41F0-9B51-8B47C874D65AQ55000948-B3D0D95D-8D7D-44FE-87BF-704D770F27C1Q55261642-AE5DD982-6A5C-4F7C-A833-B311208F4B3BQ55428911-9C5CEC84-2C47-4E9B-929D-8412A887D73B
P2860
Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis.
@en
type
label
Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis.
@en
prefLabel
Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis.
@en
P2860
P356
P1476
Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis.
@en
P2093
P2860
P304
P356
10.1111/APT.12592
P407
P577
2014-01-06T00:00:00Z